首页> 美国卫生研究院文献>Journal of Neuropathology and Experimental Neurology >Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling
【2h】

Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling

机译:胶质瘤干细胞但不是大胶质瘤细胞通过Toll样受体4信号上调小胶质细胞/脑巨噬细胞中的IL-6分泌。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peripheral macrophages and resident microglia constitute the dominant glioma-infiltrating cells. The tumor induces an immunosuppressive and tumor-supportive phenotype in these glioma-associated microglia/brain macrophages (GAMs). A subpopulation of glioma cells acts as glioma stem cells (GSCs). We explored the interaction between GSCs and GAMs. Using CD133 as a marker of stemness, we enriched for or deprived the mouse glioma cell line GL261 of GSCs by fluorescence-activated cell sorting (FACS). Over the same period of time, 100 CD133+ GSCs had the capacity to form a tumor of comparable size to the ones formed by 10,000 CD133- GL261 cells. In IL-6-/- mice, only tumors formed by CD133+ cells were smaller compared with wild type. After stimulation of primary cultured microglia with medium from CD133-enriched GL261 glioma cells, we observed an selective upregulation in microglial IL-6 secretion dependent on Toll-like receptor (TLR) 4. Our results show that GSCs, but not the bulk glioma cells, initiate microglial IL-6 secretion via TLR4 signaling and that IL-6 regulates glioma growth by supporting GSCs. Using human glioma tissue, we could confirm the finding that GAMs are the major source of IL-6 in the tumor context.
机译:周围巨噬细胞和驻留的小胶质细胞构成了主要的胶质瘤浸润细胞。在这些与神经胶质瘤相关的小胶质细胞/脑巨噬细胞(GAM)中,肿瘤诱导了免疫抑制和肿瘤支持表型。神经胶质瘤细胞的亚群充当神经胶质瘤干细胞(GSC)。我们探索了GSC和GAM之间的相互作用。使用CD133作为干性标记,我们通过荧光激活细胞分选(FACS)富集或剥夺了小鼠胶质瘤细胞系GL261的GSC。在同一时间段内,100个CD133 + GSC具有形成与10,000个CD133 - GL261细胞形成的肿瘤大小相当的肿瘤的能力。在IL-6 -/-小鼠中,只有CD133 + 细胞形成的肿瘤比野生型小。用富含CD133的GL261胶质瘤细胞的培养基刺激原代培养的小胶质细胞后,我们观察到依赖于Toll样受体(TLR)4的小胶质IL-6分泌选择性上调。我们的结果表明,GSCs而非大量的神经胶质瘤细胞,通过TLR4信号启动小胶质细胞IL-6的分泌,而IL-6通过支持GSC调节神经胶质瘤的生长。使用人类神经胶质瘤组织,我们可以证实这一发现,即GAM是肿瘤背景中IL-6的主要来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号